Tech Company Financing Transactions
Kineta Funding Round
On 9/26/2017, Kineta raised $9 million in investment from private investors.
Transaction Overview
Company Name
Announced On
9/26/2017
Transaction Type
Venture Equity
Amount
$9,000,000
Round
Undisclosed
Investors
Proceeds Purpose
Proceeds purposes were not disclosed. 1 investor participated in the offering. The amount may include options, warrants or other securities. Contact technology company for investment details, if applicable. Not an offer or solicitation for the sale of securities or debt. SEC regulatory filing.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
219 Terry Ave. N 300
Seattle, WA 98109
USA
Seattle, WA 98109
USA
Phone
Website
Email Address
Overview
Through Kineta, our pioneering team is dedicated to further study of innate immunity with an aggressive strategy to develop early stage programs for powerful new antiviral and immune modulating drugs.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Shawn Iadonato
Controller
Chanya Swartz
President
Craig Philips
Vice President
Thierry Guillaudeux
VP - Bus. Development
Jacques Bouchy
VP - General Counsel
Pauline Kenny
VP - Human Resources
Molly Dorr
VP - R & D
Eric Tarcha
Browse more venture capital transactions:
Prev: 9/26/2017: Jopwell venture capital transaction
Next: 9/26/2017: Alcresta Therapeutics venture capital transaction
Share this article
About Database of VC Transactions
We do our best to document tech company VC transactions. VC investment data records on this site are derived from company press releases and news coverage. The information is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs